期刊
AMERICAN JOURNAL OF MEDICINE
卷 124, 期 1, 页码 -出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2010.08.005
关键词
Alpha-lipoic acid; Anti-obesity agent; Side effect
资金
- Korea Health Industry Development Institute [0412-DB00-0101-0006]
- Dalim BioTech Co, Ltd, Seoul, Republic of Korea
PURPOSE: Alpha-lipoic acid is an essential cofactor for mitochondrial respiratory enzymes that improves mitochondrial function. We previously reported that alpha-lipoic acid markedly reduced body weight gain in rodents. The purpose of this study was to determine whether alpha-lipoic acid reduces body weight in obese human subjects. METHODS: In this randomized, double-blind, placebo-controlled, 20-week trial, 360 obese individuals (body mass index [BMI] >= 30 kg/m(2) or BMI 27-30 kg/m(2) plus hypertension, diabetes mellitus, or hypercholesterolemia) were randomized to alpha-lipoic acid 1200 or 1800 mg/d or placebo. The primary end point was body weight change from baseline to end point. RESULTS: The 1800 mg alpha-lipoic acid group lost significantly more weight than the placebo group (2.1%; 95% confidence interval, 1.4-2.8; P < .05). Urticaria and itching sensation were the most common adverse events in the alpha-lipoic acid groups, but these were generally mild and transient. CONCLUSION: Alpha-lipoic acid 1800 mg/d led to a modest weight loss in obese subjects. Alpha-lipoic acid may be considered as adjunctive therapy for obesity. (C) 2011 Elsevier Inc. All rights reserved. The American Journal of Medicine (2011) 124, 85.e1-85.e8
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据